Richard DeVos

Richard DeVos was the kind of American businessman who understood that optimism could be monetized before it could be measured. Born in 1926, he helped build Amway into a cultural force by treating home-based selling not as a fringe tactic but as a moral project: ordinary people, he believed, should be able to acquire prosperity through effort, persuasion, and disciplined belief in the system. That conviction made him more than an executive. It made him an architect of a commercial faith.

DeVos's psychology mattered because he was not simply selling soap. He was selling a story in which business success could be detached from salary, geography, and formal credentials. That story appealed to people who felt shut out of conventional ladders, and it also insulated the company from criticism. If recruits failed, the failure could be reframed as insufficient commitment. If they succeeded only marginally, the model could still be called democratic. This was the genius and the danger of his worldview: it transformed structural limitation into personal choice.

He was also a political operator in the broader sense of the word. DeVos understood legitimacy as a performance supported by institutions, public language, and allies who could repeat the same claims in different rooms. The 1979 FTC ruling did not merely vindicate a business model; it validated a philosophy of self-justifying capitalism that would later echo through direct selling and network marketing. In that sense, DeVos did not just co-found Amway. He helped establish the modern grammar of the MLM defense.

The contradiction at the center of his life is that he is often remembered as a benefactor and philanthropist, even as critics saw in Amway a system that externalized risk onto the hopeful. Those two truths can coexist. DeVos's legacy is not reducible to villainy or virtue. He was a builder of institutions, a patron of causes, and a man who believed, with almost evangelical certainty, that markets could redeem personal ambition. But the same confidence that made him compelling also made it difficult for him, and for the system he built, to see the harm distributed below the level of success stories.

His fate was not a courtroom ending but a historical one. He died in 2018 having outlived the original legal controversy and having watched the business model he helped legitimize become one of the most contested forms of consumer capitalism in America. He remains central to the case because the Amway defense did not emerge from nowhere; it emerged from the worldview he embodied.